• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

US pays $1B to nearly double supply of Merck's COVID-19 pill

cafead

Administrator
Staff member
  • cafead   Nov 09, 2021 at 11:12: AM
via The U.S. government has agreed to pay Merck & Co. about $1 billion for another 1.4 million treatment courses of its COVID-19 pill molnupiravir, nearly doubling its stockpile ahead of potential Food and Drug Administration authorization next month.

article source